文献速递焦虑、强迫与应激相关障碍

成功治疗创伤后应激障碍可逆转DNA甲基化标记

Successful treatment of post-traumatic stress disorder reverses DNA methylation marks.
PubMed 文献 · Mol Psychiatry · 2019-10-23

本研究探讨创伤后应激障碍(PTSD)成功治疗后血液全基因组DNA甲基化水平是否恢复。在军人队列中,缓解组(N=21)、未缓解组(N=23)和创伤暴露对照组(N=23)接受聚焦创伤心理治疗,成功治疗伴随12个差异甲基化区域(DMRs)的显著变化。在独立前瞻队列(N=85)中,ZFP57甲基化变化与PTSD症状变化相关(B=-0.84,t=-2.49,p=0.014)。

要点

  • PTSD成功治疗伴随12个DMRs的DNA甲基化显著变化。
  • ZFP57甲基化变化与PTSD症状变化前瞻性相关(B=-0.84,t=-2.49,p=0.014)。
  • ZFP57甲基化增加与症状减少相关,且独立于症状减少。

核心结论

  • 纵向证据表明ZFP57甲基化参与部署相关PTSD的发展和成功治疗。

研究设计与样本

  • 纵向研究检测军人接受聚焦创伤心理治疗后血液全基因组DNA甲基化变化,包括缓解组(N=21)、未缓解组(N=23)和创伤暴露对照组(N=23)。
  • 独立前瞻队列(N=85)检验DMRs与部署相关PTSD发展的相关性。

主要发现

  • 成功治疗PTSD伴随12个DMRs的DNA甲基化显著变化,涉及APOB、MUC4、EDN2、ZFP57、GPX6、CFAP45、AFF3、TP73、UBCLP1、RPL13P及两个基因间区域(p值<0.0001,经置换和敏感性分析确认)。
  • 12个DMRs中,ZFP57甲基化变化与PTSD症状变化前瞻性相关(B=-0.84,t=-2.49,p=0.014)。
  • ZFP57甲基化增加与PTSD症状减少相关,且独立于症状减少。

关键数值与推荐

  • 成功治疗PTSD伴随12个DMRs的DNA甲基化显著变化(p值<0.0001)。
  • ZFP57甲基化变化与PTSD症状变化相关(B=-0.84,t=-2.49,p=0.014)。

临床怎么用

  • 心理治疗可能产生独立于症状减少的生物学效应,ZFP57甲基化或可作为PTSD治疗反应的生物标记。

局限性

  • 研究为首次探索,样本量有限,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epigenetic mechanisms play a role in the detrimental effects of traumatic stress and the development of post-traumatic stress disorder (PTSD). However, it is unknown whether successful treatment of PTSD restores these epigenetic marks. This study investigated longitudinal changes of blood-based genome-wide DNA methylation levels in relation to trauma-focused psychotherapy for PTSD in soldiers that obtained remission (N = 21), non-remitted PTSD patients (N = 23), and trauma-exposed military controls (N = 23). In an independent prospective cohort, we then examined whether these DMRs were also relevant for the development of deployment-related PTSD (N = 85). Successful treatment of PTSD was accompanied by significant changes in DNA methylation at 12 differentially methylated regions (DMRs) in the genes: APOB, MUC4, EDN2, ZFP57, GPX6, CFAP45, AFF3, TP73, UBCLP1, RPL13P, and two intergenic regions (p values < 0.0001 were confirmed using permutation and sensitivity analyses). Of the 12 DMRs related to PTSD symptom reduction, consistent prospective evidence was found for ZFP57 methylation changes related to changing PTSD symptoms (B = -0.84, t = -2.49, p = 0.014). Increasing ZFP57 methylation related to PTSD symptom reduction was present over and above the relation with symptoms, suggesting that psychological treatments exert biological effects independent of symptom reduction. Together, these data provide longitudinal evidence that ZFP57 methylation is involved in both the development and successful treatment of deployment-related PTSD. This study is a first step to disentangle the interaction between psychological and biological systems to identify genomic regions relevant for the etiology and treatment of stress-related disorders such as PTSD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Vinkers CH, Geuze E, van Rooij SJH, et al. Successful treatment of post-traumatic stress disorder reverses DNA methylation marks. Mol Psychiatry. 2019. PMID: 31645664. doi:10.1038/s41380-019-0549-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。